Kevin Alan Schulman

Adjunct Professor in the Department of Medicine
Director, Center for Clinical and Genetic Economics
Research Professor of Global Health
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Email address kevin.schulman@duke.edu

Kevin A. Schulman, MD, MBA, is a professor of medicine and the Gregory Mario and Jeremy Mario Professor of Business Administration (2010 - 2016) at Duke University. He is a visiting professor of business administration at Harvard Business School. He holds several leadership appointments at Duke. He is an associate director of the Duke Clinical Research Institute in the School of Medicine, the country's largest academic clinical research organization. In Duke's Fuqua School of Business, he served for more than a decade as the director of the Health Sector Management program, the Master of Management in Clinical Informatics degree program, and the Center for the Study of Health Management. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Medicine Institute; and the Duke Global Health Institute.

Dr. Schulman is a distinguished researcher who has received more than $48 million in research grants. His research interests include health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; health economics and economic evaluation in clinical research; and medical decision making, especially in patients with life-threatening conditions. He teaches courses in biotechnology, health policy, and health IT strategy.

Dr. Schulman has published nearly 400 articles and book chapters; his peer-reviewed papers have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is the senior associate editor of Health Services Research and a member of the editorial/advisory boards of the American Journal of Medicine and the American Heart Journal.

A recipient of numerous awards, Dr. Schulman is a fellow of the American College of Physicians and an elected member of the American Society for Clinical Investigation. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. He has served as session chair and panelist at dozens of medical and health care conferences. Dr. Schulman has also served on numerous grant review committees for the National Institutes of Health, the Robert Wood Johnson Foundation, and other bodies. He is a member of the advisory board for the Centre for Healthcare Policy and Management at the China Europe International Business School. In 2010-2011, he was a mentor for the Commonwealth Fund's Harkness Fellowships in Health Care Policy and Practice. He is the founding president of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.

Dr. Schulman received his MD from the New York University School of Medicine and his MBA, with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board-certified in internal medicine.

Publications

Reed, SD, Kaul, P, Hernandez, AF, Li, Y, Eapen, ZJ, Schulman, KA, Whellan, DJ, Westerhout, CM, Massie, B, Howlett, JG, Armstrong, PW, Starling, R, O'Connor, CM, and Califf, RM. "Medical Resource Use, Costs and Quality of Life are Similar Between Patients with Acute Decompensated Heart Failure Treated with Nesiritide Versus Placebo." CIRCULATION 124, no. 21 (November 22, 2011).

Scholars@Duke

"Erratum: Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures." American Journal of Hematology 86, no. 10 (October 2011): 906-908.

Full Text

Reed, SD, Eapen, ZJ, and Schulman, KA. "End point selection in acute decompensated heart failure clinical trials: economic end points." Heart Fail Clin 7, no. 4 (October 2011): 529-537. (Review)

PMID
21925436
Full Text

Sullivan, R, Peppercorn, J, Sikora, K, Zalcberg, J, Meropol, NJ, Amir, E, Khayat, D, Boyle, P, Autier, P, Tannock, IF, Fojo, T, Siderov, J, Williamson, S, Camporesi, S, McVie, JG, Purushotham, AD, Naredi, P, Eggermont, A, Brennan, MF, Steinberg, ML, De Ridder, M, McCloskey, SA, Verellen, D, Roberts, T, Storme, G, Hicks, RJ, Ell, PJ, Hirsch, BR, Carbone, DP, Schulman, KA, Catchpole, P, Taylor, D, Geissler, J, Brinker, NG, Meltzer, D, Kerr, D, and Aapro, M. "Delivering affordable cancer care in high-income countries." The Lancet. Oncology 12, no. 10 (September 2011): 933-980.

PMID
21958503
Full Text

Sampson, JH, Kaminski, TJ, and Schulman, KA. "Our failure to advance new treatments for glioma to market." J Neurosurg 115, no. 2 (August 2011): 245-247.

PMID
21568655
Full Text

Wiener, JS, Antonelli, J, Shea, AM, Curtis, LH, Schulman, KA, Krupski, TL, and Scales, CD. "Bladder augmentation versus urinary diversion in patients with spina bifida in the United States." J Urol 186, no. 1 (July 2011): 161-165.

PMID
21575969
Full Text

Ackerly, DC, Sangvai, DG, Udayakumar, K, Shah, BR, Kalman, NS, Cho, AH, Schulman, KA, Fulkerson, WJ, and Dzau, VJ. "Training the next generation of physician-executives: an innovative residency pathway in management and leadership." Academic Medicine : Journal of the Association of American Medical Colleges 86, no. 5 (May 2011): 575-579. (Review)

PMID
21436663
Full Text

Dinan, MA, Compton, KL, Dhillon, JK, Hammill, BG, Dewitt, EM, Weinfurt, KP, and Schulman, KA. "Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials." Medical Care 49, no. 4 (April 2011): 415-419. (Review)

PMID
21368680
Full Text

Glickman, SW, Ndubuizu, A, Weinfurt, KP, Hamilton, CD, Glickman, LT, Schulman, KA, and Cairns, CB. "Perspective: The case for research justice: inclusion of patients with limited English proficiency in clinical research." Acad Med 86, no. 3 (March 2011): 389-393.

PMID
21248607
Full Text

Reed, SD, Scales, CD, Stewart, SB, Sun, J, Moul, JW, Schulman, KA, and Xu, J. "Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer." J Urol 185, no. 3 (March 2011): 841-847.

PMID
21239023
Full Text

Pages